Drug Class
IDH1 inhibitor
Type
brand
Active Ingredient
ivosidenib
📋Overview
Tibsovo is a medication that targets specific genetic mutations found in certain types of cancer cells. It is most commonly associated with the treatment of acute myeloid leukemia (AML) and cholangiocarcinoma, particularly in patients whose cancer cells have an IDH1 mutation. By inhibiting the abnormal enzyme produced by this mutation, Tibsovo can help slow the growth of cancer cells. Its use is based on the presence of this specific genetic alteration in the tumor.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Tibsovo
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.